These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
222 related items for PubMed ID: 29629730
1. Icatibant Outcome Survey in Patients with Hereditary Angioedema: Experience in Israel Compared with Other Countries. Toubi E, Kivity S, Graif Y, Reshef A, Botha J, Andresen I. Isr Med Assoc J; 2018 Apr; 20(4):227-232. PubMed ID: 29629730 [Abstract] [Full Text] [Related]
3. Management of patients with hereditary angioedema in Germany: comparison with other countries in the Icatibant Outcome Survey. Maurer M, Bork K, Martinez-Saguer I, Aygören-Pürsün E, Botha J, Andresen I, Magerl M. J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):163-169. PubMed ID: 30176179 [Abstract] [Full Text] [Related]
5. Icatibant use in Brazilian patients with hereditary angioedema (HAE) type 1 or 2 and HAE with normal C1-INH levels: findings from the Icatibant Outcome Survey Registry Study. Grumach AS, Henriques MT, Bardou MLD, Pontarolli DA, Botha J, Correa M, IOS Brazil Study Group. An Bras Dermatol; 2022 Jan; 97(4):448-457. PubMed ID: 35654647 [Abstract] [Full Text] [Related]
6. Treatment of HAE Attacks in the Icatibant Outcome Survey: An Analysis of Icatibant Self-Administration versus Administration by Health Care Professionals. Hernández Fernandez de Rojas D, Ibañez E, Longhurst H, Maurer M, Fabien V, Aberer W, Bouillet L, Zanichelli A, Caballero T, IOS Study Group. Int Arch Allergy Immunol; 2015 Jan; 167(1):21-8. PubMed ID: 26112099 [Abstract] [Full Text] [Related]
17. Modeling Cost-Effectiveness of On-Demand Treatment for Hereditary Angioedema Attacks. Bernstein JA, Tyson C, Relan A, Adams P, Magar R. J Manag Care Spec Pharm; 2020 Feb; 26(2):203-210. PubMed ID: 31841366 [Abstract] [Full Text] [Related]
18. Icatibant as acute treatment for hereditary angioedema in adults. Farkas H. Expert Rev Clin Pharmacol; 2016 Jun; 9(6):779-88. PubMed ID: 27123689 [Abstract] [Full Text] [Related]
19. Open-label, multicenter study of self-administered icatibant for attacks of hereditary angioedema. Aberer W, Maurer M, Reshef A, Longhurst H, Kivity S, Bygum A, Caballero T, Bloom B, Nair N, Malbrán A. Allergy; 2014 Mar; 69(3):305-14. PubMed ID: 24438203 [Abstract] [Full Text] [Related]